Financial statements Bio2Materials
Balance sheet data of BIO2MATERIALS
Year
|
2018
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|
Total assets | 6 253,14 | 1 069 872,71 | 4 874 758,45 | 3 410 829,11 | 2 387 372,60 |
A. Fixed assets | 5 000,00 | 57 169,72 | 809 214,93 | 1 883 402,96 | 1 303 175,61 |
B. Current assets | 1 253,14 | 1 012 702,99 | 4 065 543,52 | 1 527 426,15 | 1 084 196,99 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Total liabilities | 6 253,14 | 1 069 872,71 | 4 874 758,45 | 3 410 829,11 | 2 387 372,60 |
A. Equity | -40 092,08 | 153 546,18 | 4 650 387,50 | 3 207 757,25 | 1 199 134,02 |
B. Liabilities and provisions for liabilities | 46 345,22 | 916 326,53 | 224 370,95 | 203 071,86 | 1 188 238,58 |
I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
II. Short-term liabilities | 46 345,22 | 133 482,64 | 224 370,95 | 201 915,63 | 1 186 924,90 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.